Detailed answers about HEALTH OPTIONS EUROPE (HOPE ) LTD, including incorporation, status, business activity, and accounts information.
When was HEALTH OPTIONS EUROPE (HOPE ) LTD founded?
HEALTH OPTIONS EUROPE (HOPE ) LTD was officially incorporated on 13 June 2012 and is registered under company number 08103474. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is HEALTH OPTIONS EUROPE (HOPE ) LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of HEALTH OPTIONS EUROPE (HOPE ) LTD?
HEALTH OPTIONS EUROPE (HOPE ) LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does HEALTH OPTIONS EUROPE (HOPE ) LTD do?
HEALTH OPTIONS EUROPE (HOPE ) LTD operates in the following sectors: 46190 - Agents involved in the sale of a variety of goods, 46460 - Wholesale of pharmaceutical goods, 46900 - Non-specialised wholesale trade, 47910 - Retail sale via mail order houses or via Internet. These SIC codes provide insight into the company's business activities and industry focus.
What is HEALTH OPTIONS EUROPE (HOPE ) LTD's registered address?
The registered office address of HEALTH OPTIONS EUROPE (HOPE ) LTD is 189 ROYAL DRIVE, PRINCESS PARK MANOR, LONDON, ENGLAND, N11 3FR. This is the official address filed with Companies House for legal and statutory correspondence.
Is HEALTH OPTIONS EUROPE (HOPE ) LTD financially stable?
The most recent accounts for HEALTH OPTIONS EUROPE (HOPE ) LTD were made up to 30 June 2024, filed as MICRO ENTITY. Next accounts are due by 31 March 2026.